Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Oncology Institute Inc (NASDAQ: TOI) closed at $0.29 up 5.36% from its previous closing price of $0.28. In other words, the price has increased by $5.36 from its previous closing price. On the day, 0.64 million shares were traded. TOI stock price reached its highest trading level at $0.32 during the session, while it also had its lowest trading level at $0.2656.
Ratios:
For a deeper understanding of Oncology Institute Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.99 and its Current Ratio is at 3.31. In the meantime, Its Debt-to-Equity ratio is 4.14 whereas as Long-Term Debt/Eq ratio is at 3.92.
On September 14, 2022, Guggenheim started tracking the stock assigning a Buy rating and target price of $7.
On August 15, 2022, Jefferies started tracking the stock assigning a Buy rating and target price of $10.Jefferies initiated its Buy rating on August 15, 2022, with a $10 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 29 ’24 when Havencrest Healthcare Partners sold 8,637 shares for $2.12 per share. The transaction valued at 18,310 led to the insider holds 0 shares of the business.
Havencrest Healthcare Partners sold 24,915 shares of TOI for $57,304 on Jan 24 ’24. The 10% Owner now owns 27,498 shares after completing the transaction at $2.30 per share. On Jan 25 ’24, another insider, Havencrest Healthcare Partners, who serves as the 10% Owner of the company, sold 11,882 shares for $2.07 each. As a result, the insider received 24,596 and left with 15,616 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TOI now has a Market Capitalization of 22269696 and an Enterprise Value of 96912696. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.06 while its Price-to-Book (P/B) ratio in mrq is 0.76. Its current Enterprise Value per Revenue stands at 0.268 whereas that against EBITDA is -1.69.
Stock Price History:
Over the past 52 weeks, TOI has reached a high of $2.65, while it has fallen to a 52-week low of $0.27. The 50-Day Moving Average of the stock is -6.93%, while the 200-Day Moving Average is calculated to be -66.01%.
Shares Statistics:
For the past three months, TOI has traded an average of 123.61K shares per day and 95950 over the past ten days. A total of 74.15M shares are outstanding, with a floating share count of 36.77M. Insiders hold about 51.30% of the company’s shares, while institutions hold 21.86% stake in the company. Shares short for TOI as of 1728950400 were 251810 with a Short Ratio of 2.04, compared to 1726185600 on 233017. Therefore, it implies a Short% of Shares Outstanding of 251810 and a Short% of Float of 0.5.
